CDC has published a Health Alert Network advisory on vitamin K-dependent antagonist coagulopathy caused by synthetic cannabinoids apparently contaminated with the rodenticide brodifacoum. While CDC does not report any cases from the West Coast, they advise proceduralists who deal with blood, and others, to be aware of the possibility. The HAN includes:
- Recommendations for clinicians, including notifying health authorities, especially in cases where a synthetic cannabinoid user has recently donated blood
- Recommendations for public health officials, including notifying CDC
- Recommendations for the general public, including avoiding synthetic cannabinoids
For details see https://emergency.cdc.gov/han/han00410.asp.
There is no suggestion that natural, non-synthetic cannabinoids are similarly contaminated; these are regulated and legal by state law in all of Networks 16 and 18 except Idaho, and increasingly used for medical purposes. There is also no suggestion that natural, non-synthetic, non-psychoactive CBD oil made from industrial hemp, which is available throughout the US, is similarly contaminated; however, outside of the regulated marketplace, industrial-hemp CBD oil is unregulated, so the potential for contamination of some kind is always present.
CDC and WHO have announced that November 13-19, 2017 will be US and World Antibiotic Awareness Week, to raise awareness about antibiotic resistance and the importance of appropriate antibiotic prescribing and use. European Antibiotic Awareness Day is November 18. CDC has updated their educational initiative Be Antibiotics Aware: Smart Use, Best Care, and aims to engage the industry and the public in efforts to improve antibiotic prescribing and use across all health care settings. Find the CDC announcement and links to Be Antibiotics Aware at https://www.cdc.gov/mmwr/volumes/66/wr/mm6644a9.htm?s_cid=mm6644a9_e and the WHO announcement at http://www.who.int/campaigns/world-antibiotic-awareness-week/en/.
The US Dept of Justice Drug Enforcement Agency Diversion Control Division will sponsor the 12th National Prescription Drug Take Back Day on April 29, 2017. To find a location near you, see https://www.deadiversion.usdoj.gov/drug_disposal/takeback/ . As of today, many locations are listed in California, Oregon, Idaho, and Montana, but fewer in Alaska and Washington. However, they are adding collection locations daily, so check back later in April if you don’t find a convenient dropoff site.
Alternative methods of disposal are detailed at https://archive.epa.gov/region02/capp/web/pdf/ppcpflyer.pdf .
CMS is seeking nominations for members of Technical Expert Panel to develop one or more quality measures related to medication reconciliation and management for ESRD patients. Nominations are due by April 24, 2017. For details see https://www.cms.gov/Medicare/Quality-Initiatives-Patient-Assessment-Instruments/MMS/TechnicalExpertPanels.html#ESRD%20Reconciliation .
The UCLA Kidney Education Enhancement Program (UKEEP) will present a free seminar for patients on February 19, 2017 in Santa Monica about Medications: What You Need to Know. RSVP requested. For details see https://s3-us-west-2.amazonaws.com/nwrn.org/files/N/UKeep021917.pdf . Don’t forget to mark your calendar for the March 26, 2017 UKEEP Kidney Fair.
The UCLA Kidney Education Enhancement Program (UKEEP) will present a free seminar for patients on February 19, 2017 in Santa Monica about Medications: What You Need to Know. RSVP requested. For details see https://s3-us-west-2.amazonaws.com/nwrn.org/files/N/UKeep021917.pdf .
They also announce that their annual Kidney Fair will occur on March 26, 2017.